Lijnen H R, van Hoef B, Collen D
Thromb Haemost. 1983 Aug 30;50(2):560-2.
The interaction between heparin, histidine-rich glycoprotein and antithrombin III was studied in purified systems. Histidine-rich glycoprotein binds heparin and thereby interferes with its interaction with antithrombin III, resulting in neutralization of the anticoagulant activity. This interaction occurs with clinical grade heparin as well as with high affinity (for antithrombin III) heparin and with a high affinity heparin fragment with Mr 4,300. Low affinity heparin competes with high affinity heparin for the binding to histidine-rich glycoprotein which results in an apparent increase of the anticoagulant activity of high affinity heparin. The interaction between heparin and histidine-rich glycoprotein is counteracted by Ca2+-binding anticoagulants, indicating that it is dependent on the presence of divalent metal ions. Ethylenediaminetetraacetate is a much more potent inhibitor of the interaction between heparin and histidine-rich glycoprotein than citrate.
在纯化系统中研究了肝素、富含组氨酸糖蛋白和抗凝血酶III之间的相互作用。富含组氨酸糖蛋白结合肝素,从而干扰其与抗凝血酶III的相互作用,导致抗凝活性的中和。这种相互作用在临床级肝素以及高亲和力(对抗凝血酶III)肝素和Mr为4300的高亲和力肝素片段中均会发生。低亲和力肝素与高亲和力肝素竞争结合富含组氨酸糖蛋白,这导致高亲和力肝素的抗凝活性明显增加。肝素与富含组氨酸糖蛋白之间的相互作用被Ca2+结合抗凝剂抵消,表明它依赖于二价金属离子的存在。乙二胺四乙酸比柠檬酸盐更有效地抑制肝素与富含组氨酸糖蛋白之间的相互作用。